ha14-1 has been researched along with Cancer of Liver in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Armeanu-Ebinger, S; Ellerkamp, V; Fuchs, J; Kirchner, B; Lieber, J; Warmann, SW; Wenz, J | 1 |
Caruso, JA; Joiakim, A; Kessel, D; Leeson, B; Mathieu, PA; Reiners, JJ; Sloane, BF | 1 |
Bradacs, G; Grabowski, P; Heine, B; Höpfner, M; Krahn, A; Maaser, K; Scherübl, H; Schuppan, D; Somasundaram, R; Stein, H; Sutter, AP; Vormbrock, K; Zeitz, M | 1 |
3 other study(ies) available for ha14-1 and Cancer of Liver
Article | Year |
---|---|
Apoptosis sensitizers enhance cytotoxicity in hepatoblastoma cells.
Topics: Apoptosis; Benzamides; Benzopyrans; Biphenyl Compounds; Blotting, Western; Cell Survival; Drug Resistance, Neoplasm; Enzyme Inhibitors; Hepatoblastoma; Humans; Indoles; Liver Neoplasms; Nitriles; Nitrophenols; Piperazines; Proto-Oncogene Proteins c-bcl-2; Pyrroles; Sulfonamides; Sulfones; Tumor Cells, Cultured | 2012 |
Differential susceptibilities of murine hepatoma 1c1c7 and Tao cells to the lysosomal photosensitizer NPe6: influence of aryl hydrocarbon receptor on lysosomal fragility and protease contents.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzopyrans; BH3 Interacting Domain Death Agonist Protein; Carcinoma, Hepatocellular; Carrier Proteins; Cathepsins; fas Receptor; Liver Neoplasms; Lysosomes; Mice; Nitriles; Photosensitizing Agents; Porphyrins; Receptors, Aryl Hydrocarbon; Triazenes; Tumor Cells, Cultured | 2004 |
Peripheral benzodiazepine receptor ligands induce apoptosis and cell cycle arrest in human hepatocellular carcinoma cells and enhance chemosensitivity to paclitaxel, docetaxel, doxorubicin and the Bcl-2 inhibitor HA14-1.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Benzopyrans; Carcinoma, Hepatocellular; Cell Cycle; Cell Division; Cell Line, Tumor; Docetaxel; Doxorubicin; Drug Synergism; Enzyme Inhibitors; Humans; Isoquinolines; Ligands; Liver Neoplasms; Nitriles; Paclitaxel; Proto-Oncogene Proteins c-bcl-2; Receptors, GABA-A; RNA, Messenger; Taxoids; Tritium | 2004 |